This inventor holds 1 USPTO granted patent. Top assignees: Korea Center for Disease Control and Prevention, The Green Cross Corporation. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2013
Title: Jeong-Hoon Chun: Innovator in Anthrax Protective Antigen Production
Introduction
Jeong-Hoon Chun is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of methods for producing protective antigens against anthrax infection. His innovative approach has the potential to enhance the efficiency and cost-effectiveness of large-scale production.
Latest Patents
Jeong-Hoon Chun holds a patent for a "Method for preparing antigen effective for preventing anthrax infection." This method involves successive column chromatography processes that purify the anthrax protective antigen. It effectively removes impurities, such as cellular residual proteins, without compromising the integrity of the protective antigen. This advancement allows for the economical large-scale production of the anthrax protective antigen.
Career Highlights
Throughout his career, Jeong-Hoon Chun has worked with prominent organizations, including the Korea Center for Disease Control and Prevention and Green Cross Corporation. His experience in these institutions has equipped him with the knowledge and skills necessary to innovate in the field of public health and biotechnology.
Collaborations
Jeong-Hoon Chun has collaborated with esteemed colleagues, including Hee-Bok Oh and Hun Rae Kim. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Jeong-Hoon Chun's work in developing methods for producing anthrax protective antigens showcases his commitment to improving public health through innovation. His contributions are vital in the ongoing efforts to combat infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile